Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -211.7% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 3.1 | n/a |
Pr/Book | 2.9 |
Latest | F'cast | |
---|---|---|
Revenue | 10.5% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 1.70 | (3.51) | (17.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 1.16 | (6.95) | (27.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 2.40 | (10.54) | (32.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 4.57 | (8.90) | (0.28)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-24 | 5.05 | (10.62) | (0.31)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Director/PDMR Dealing | 21-May-2025 | 07:00 | RNS |
Arecor Partnership with Skye Bioscience | 19-May-2025 | 07:00 | RNS |
Director Dealing | 14-May-2025 | 14:37 | RNS |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
19-May-25 | Buy | Sarah Jennifer Howell | 46.97p | 21,077 | £9,899.87 |
19-May-25 | Buy | Andrew Richards | 46.97p | 31,750 | £14,912.98 |
13-May-25 | Buy | Andrew Richards | 41.25p | 35,000 | £14,437.50 |
Currency | UK Pounds |
Share Price | 41.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 160.00 |
52 Week Low | 38.00 |
Volume | 701 |
Shares Issued | 37.76m |
Market Cap | £15.67m |
Beta | 0.01 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
11:42 | 698 @ 42.94p |
10:23 | 3 @ 43.00p |
CEO | Sarah Jennifer Howell |
CFO | David Ellam |
You are here: research